Absorption, metabolism and excretion of [¹⁴C]gemigliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans

By Kim Namtae   Patrick Lorna   Mair Stuart   Stevens Lloyd   Ford Gill   Birks Vicky   Lee Sung-Hack  

Xenobiotica, Vol. 44, Iss. 6, 2014-06 ,pp. : 522-530

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and metabolism of the dipeptidyl peptidase IV inhibitor carmegliptin in rats, dogs, and monkeys

By Kuhlmann Olaf   Paehler Axel   Weick Idelette   Funk Christoph   Pantze Michael   Zell Manfred   Timm Uwe  

Xenobiotica, Vol. 40, Iss. 12, 2010-12 ,pp. : 840-852

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of lipoyl vildagliptin, a novel dipeptidyl peptidase IV inhibitor after oral administration in rats

By Wang X.   Zhang D.   Xu W.   Liu H.   Wang W.  

Xenobiotica, Vol. 40, Iss. 10, 2010-10 ,pp. : 707-712

Informa Healthcare

Access to resources Recommend Favorite

In vitro metabolism and transport of the new dipeptidyl peptidase 4 inhibitors, KR66222 and KR66223

By Ahn Hee Jeong   Kim Kwon-Bok   Liu Kwang-Hyeon   Shin Jae-Gook   Ahn Jin Hee   Kim Min-Sun   Bae Myung-Ae   Song Im-Sook  

Xenobiotica, Vol. 41, Iss. 6, 2011-06 ,pp. : 445-455

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Dipeptidyl Peptidase-4 (DPP-4) - A Novel Approach to Treat Type 2 Diabetes

By  

Current Enzyme Inhibition, Vol. 1, Iss. 1, 2005-01 ,pp. : 65-73

Bentham Science Publishers

Access to resources Recommend Favorite